R&D activities around GynEC®-DX aim to validate its use in certain clinic profiles for which information cannot be obtained through other techniques. The clinical study led by La Paz hospital (Madrid) aims to validate the use of GynEC®-DX in the biomarkers-guided surveillance of patients with Lynch syndrome. Preliminary results have been presented at 34th National Congress of the Gynecologic Oncology Section of the Spanish Society of Gynecology and Obstetrics (SEGO) hold recently in Barcelona.
Poster: Resultados preliminares del estudio: “Aproximación Multidisciplinar al Síndrome de Lynch. Diagnóstico Molecular de Cáncer De Endometrio”.
Boria F, Cruz-Rei MI, Diestro MD, Zapardiel I, Hernández-Gutierrez A
Hospital Universitario La Paz, Madrid, España